ATS Corporation has successfully finalized the acquisition of 100% of Avidity Science, integrating the entity into its growing Life Sciences platform. This strategic transaction is designed to establish a comprehensive suite of laboratory automation and water purification technologies, significantly enhancing the group's ability to serve global biomedical research facilities. The strategic rationale for the move centers on the high degree of technical complementarity between the target’s specialized water systems and the group's existing automation and fluid handling capabilities. By incorporating the target’s established customer base and proprietary filtration solutions, the organization bolsters its value proposition as a primary provider of mission-critical lab infrastructure. The partnership is focused on leveraging the group's global aftermarket service network to drive recurring revenue from consumables and maintenance services. This integration reinforces the organization’s standing as a leading enabler of technical innovation in the life sciences sector, providing the strategic depth required to support high-growth biopharmaceutical research and diagnostics applications worldwide. This move marks a significant densification of the group's presence in the scientific fluid management landscape.

AVIDITY SCIENCE, which reported an EBITDA margin of LOGIN in 2023, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN premium to the 10.2x average currently observed in the Industry & Manufacturing sector.

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.